M. Hervé

Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.

I. Bièche, M. Perrot-Applanat, S. Mourah, 2008, The American journal of pathology.

Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.

T. Domet, M. Perrot-Applanat, S. Mourah, 2006, The Journal of endocrinology.

Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.

M. Crépin, M. Hervé, R. Vassy, 2004, Anticancer research.

Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism

C. Legrand, M. Perrot-Applanat, S. Chollet-Martin, 2004, Laboratory Investigation.

VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.

M. Perrot-Applanat, F. Calvo, S. Mourah, 2005, Experimental cell research.

Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.

M. Hervé, Hélène Buteau-Lozano, Martine Perrot Applanat, 2008, Advances in experimental medicine and biology.